HomeCMMB • NASDAQ
add
Chemomab Therapeutics Ltd - ADR
Previous close
$1.29
Day range
$1.29 - $1.41
Year range
$0.78 - $2.55
Market cap
25.83M USD
Avg Volume
99.37K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.49M | -13.86% |
Net income | -3.32M | 14.09% |
Net profit margin | — | — |
Earnings per share | -0.01 | 50.00% |
EBITDA | -3.47M | 13.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.56M | -33.47% |
Total assets | 12.82M | -28.82% |
Total liabilities | 2.43M | -48.14% |
Total equity | 10.39M | — |
Shares outstanding | 18.86M | — |
Price to book | 2.35 | — |
Return on assets | -58.54% | — |
Return on capital | -71.03% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.32M | 14.09% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Website
Employees
16
